Impact of housing on the survival of persons with AIDS

详细信息    查看全文

• 作者：Sandra K Schwarcz (1) (2)
  Ling C Hsu (1)
  Eric Vittinghoff (2)
  Annie Vu (1)
  Joshua D Bamberger (1)
  Mitchell H Katz (1) (2)
  
• 刊名：BMC Public Health
• 出版年：2009
• 出版时间：December 2009
• 年：2009
• 卷：9
• 期：1
• 全文大小：616KB
• 参考文献：1. Hanzlick R, Parrish RG: Deaths among the homeless in Fulton County, GA, 1988鈥?0. / Public Health Rep 1993, 108: 488鈥?1.
  2. Hibbs JR, Benner L, Klugman L, Spencer R, Macchia I, Mellinger A, Fife DK: Mortality in a cohort of homeless adults in Philadelphia. / N Engl J Med 1994, 331: 304鈥?. CrossRef
  3. Hwang SW: Is homelessness hazardous to your health? Obstacles to the demonstration of a causal relationship. / Can J Public Health 2002, 93: 407鈥?0.
  4. Barrow SM, Herman DB, Cordova P, Struening EL: Mortality among homeless shelter residents in New York City. / Am J Public Health 1999, 89: 529鈥?4. CrossRef
  5. Fischer PJ, Breakey WR: The epidemiology of alcohol, drug, and mental disorders among homeless persons. / Am Psychol 1991, 46: 1115鈥?8. CrossRef
  6. Riley ED, Bangsberg DR, Guzman D, Perry S, Moss AR: Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed. / J Acquir Immune Defic Syndr 2005, 38: 191鈥?. CrossRef
  7. Susser E, Struening EL, Conover S: Psychiatric problems in homeless men. Lifetime psychosis, substance use, and current distress in new arrivals at New York City shelters. / Arch Gen Psychiatry 1989, 46: 845鈥?0.
  8. La Gory M, Ritchey FJ, Mullis J: Depression among the homeless. / J Health Soc Behav 1990, 31: 87鈥?02. CrossRef
  9. Weiser SD, Riley ED, Ragland K, Hammer G, Clark R, Bangsberg DR: Brief report: Factors associated with depression among homeless and marginally housed HIV-infected men in San Francisco. / J Gen Intern Med 2006, 21: 61鈥?. CrossRef
  10. Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, Pilote L, Moss AR: HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. / JAMA 1994, 272: 455鈥?1. CrossRef
  11. Torres RA, Mani S, Altholz J, Brickner PW: Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection. / Arch Intern Med 1990, 150: 2030鈥?. CrossRef
  12. Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM: Viral hepatitis and other infectious diseases in a homeless population. / J Clin Gastroenterol 2002, 34: 476鈥?0. CrossRef
  13. Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, Constantine NT: Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. / Compr Psychiatry 2003, 44: 293鈥?02. CrossRef
  14. Hwang SW, O'Connell JJ, Lebow JM, Bierer MF, Orav EJ, Brennan TA: Health care utilization among homeless adults prior to death. / J Health Care Poor Underserved 2001, 12: 50鈥?.
  15. Kushel MB, Vittinghoff E, Haas JS: Factors associated with the health care utilization of homeless persons. / JAMA 2001, 285: 200鈥?. CrossRef
  16. Arno PS, Bonuck KA, Green J, Fleishman J, Bennett CL, Fahs MC, Maffeo C, Drucker E: The impact of housing status on health care utilization among persons with HIV disease. / J Health Care Poor Underserved 1996, 7: 36鈥?9.
  17. Kidder DP, Wolitski RJ, Campsmith ML, Nakamura GV: Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. / Am J Public Health 2007, 97: 2238鈥?5. CrossRef
  18. Kim TW, Kertesz SG, Horton NJ, Tibbetts N, Samet JH: Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. / BMC Health Serv Res 2006, 6: 19. CrossRef
  19. Masson CL, Sorensen JL, Phibbs CS, Okin RL: Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. / AIDS Care 2004, 16: 744鈥?5. CrossRef
  20. Smith MY, Rapkin BD, Winkel G, Springer C, Chhabra R, Feldman IS: Housing status and health care service utilization among low-income persons with HIV/AIDS. / J Gen Intern Med 2000, 15: 731鈥?. CrossRef
  21. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD: Self-reported antiretroviral therapy in injection drug users. / JAMA 1998, 280: 544鈥?. CrossRef
  22. Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR: Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. / Clin Infect Dis 2004, 39: 1190鈥?. CrossRef
  23. Lebow JM, O'Connell JJ, Oddleifson S, Gallagher KM, GR Seage 3rd, Freedberg KA: AIDS among the homeless of Boston: a cohort study. / J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8: 292鈥?. CrossRef
  24. Lieb S, Brooks RG, Hopkins RS, Thompson D, Crockett LK, Liberti T, Jani AA, Nadler JP, Virkud VM, West KC, / et al.: Predicting death from HIV/AIDS: a case-control study from Florida public HIV/AIDS clinics. / J Acquir Immune Defic Syndr 2002, 30: 351鈥?.
  25. Walley AY, Cheng DM, Libman H, Nunes D, CR Horsburgh Jr, Saitz R, Samet JH: Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems. / AIDS 2008, 22: 415鈥?0. CrossRef
  26. The San Francisco Department of Public Health: The San Francisco Department of Public Health HIV/AIDS Epidemiology Report, 2006. 2007, 51.
  27. Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP: Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). / J Acquir Immune Defic Syndr 1994, 7: 287鈥?5.
  28. Mocroft A, Youle M, Morcinek J, Sabin CA, Gazzard B, Johnson MA, Phillips AN: Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. / BMJ 1997, 314: 409鈥?3.
  29. Phillips AN, Gazzard B, Gilson R, Easterbrook P, Johnson M, Walsh J, Leen C, Fisher M, Orkin C, Anderson J, / et al.: Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count. / AIDS 2007, 21: 1717鈥?1. CrossRef
  30. Willan AR BA: Statistical analysis of cost-effectiveness data. West Sussex, England: Wiley 2006. CrossRef
  31. Efron B TR: An Introduction to the Bootstrap. Boca Raton: Chapman & Hall/CRC 1998.
  32. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV: Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. / Ann Intern Med 2006, 145: 397鈥?06.
  33. Nash D, Katyal M, Shah S: Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993鈥?001. / J Urban Health 2005, 82: 584鈥?00.
  34. Miller CL, Kerr T, Strathdee SA, Li K, Wood E: Factors associated with premature mortality among young injection drug users in Vancouver. / Harm Reduct J 2007, 4: 1. CrossRef
  35. Vlahov D, Wang CL, Galai N, Bareta J, Mehta SH, Strathdee SA, Nelson KE: Mortality risk among new onset injection drug users. / Addiction 2004, 99: 946鈥?4. CrossRef
  36. Copeland L, Budd J, Robertson JR, Elton RA: Changing patterns in causes of death in a cohort of injecting drug users, 1980鈥?001. / Arch Intern Med 2004, 164: 1214鈥?0. CrossRef
  37. Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT: Impact of HIV infection on mortality in a cohort of injection drug users. / J Acquir Immune Defic Syndr 2001, 28: 351鈥?.
  38. CDC: HIV/AIDS Surveillance Report, 2007. 2009, 19: 9.
  39. Espinoza L, Hall HI, Hardnett F, Selik RM, Ling Q, Lee LM: Characteristics of persons with heterosexually acquired HIV infection, United States 1999鈥?004. / Am J Public Health 2007, 97: 144鈥?. CrossRef
  40. Schwarcz S, Hsu L, Dilley JW, Loeb L, Nelson K, Boyd S: Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. / J Acquir Immune Defic Syndr 2006, 43: 491鈥?. CrossRef
  41. Bhattacharya J, Goldman D, Sood N: The link between public and private insurance and HIV-related mortality. / J Health Econ 2003, 22: 1105鈥?2. CrossRef
  42. Joyce GF, Goldman DP, Leibowitz A, Carlisle D, Duan N, Shapiro MF, Bozzette SA: Variation in inpatient resource use in the treatment of HIV: do the privately insured receive more care? / Med Care 1999, 37: 220鈥?. CrossRef
  43. Cunningham WE, Markson LE, Andersen RM, Crystal SH, Fleishman JA, Golin C, Gifford A, Liu HH, Nakazono TT, Morton S, / et al.: Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. / J Acquir Immune Defic Syndr 2000, 25: 115鈥?3. CrossRef
  44. Hsu LC, Vittinghoff E, Katz MH, Schwarcz SK: Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996鈥?999. / J Acquir Immune Defic Syndr 2001, 28: 345鈥?0.
  45. Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, Athey LA, Keesey JW, Goldman DP, Berry SH, / et al.: Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. / JAMA 1999, 281: 2305鈥?5. CrossRef
  46. Martinez TE, Burt MR: Impact of permanent supportive housing on the use of acute care health services by homeless adults. / Psychiatr Serv 2006, 57: 992鈥?. CrossRef
  47. Tsemberis S, Gulcur L, Nakae M: Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. / Am J Public Health 2004, 94: 651鈥?. CrossRef
  48. Sadowski LS, Kee RA, Weele TJ, Buchanan D: Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. / Jama 2009, 301: 1771鈥?. CrossRef
  49. Rosenheck R, Kasprow W, Frisman L, Liu-Mares W: Cost-effectiveness of supported housing for homeless persons with mental illness. / Arch Gen Psychiatry 2003, 60: 940鈥?1. CrossRef
  50. Kushel MB, Colfax G, Ragland K, Heineman A, Palacio H, Bangsberg DR: Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. / Clin Infect Dis 2006, 43: 234鈥?2. CrossRef
  51. Katz MH, Cunningham WE, Fleishman JA, Andersen RM, Kellogg T, Bozzette SA, Shapiro MF: Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. / Ann Intern Med 2001, 135: 557鈥?5.
  52. Aidala A, Cross JE, Stall R, Harre D, Sumartojo E: Housing status and HIV risk behaviors: implications for prevention and policy. / AIDS Behav 2005, 251鈥?5.
  53. Holtgrave DR, Briddell K, Little E, Bendixen AV, Hooper M, Kidder DP, Wolitski RJ, Harre D, Royal S, Aidala A: Cost and threshold analysis of housing as an HIV prevention intervention. / AIDS Behav 2007, 11: 162鈥?. CrossRef
  54. Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC: Evaluating the cost-effectiveness of clinical and public health measures. / Annu Rev Public Health 1998, 19: 125鈥?2. CrossRef
  55. Neumann PJ, Rosen AB, Weinstein MC: Medicare and cost-effectiveness analysis. / N Engl J Med 2005, 353: 1516鈥?2. CrossRef
  56. Houghton T: The New York/New York agreement cost study: the impact of supportive housing on service use for homeless mentally ill individuals. Corporation for Supportive Housing, New York, New York 2001.
  57. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/9/220/prepub
  
• 作者单位：Sandra K Schwarcz (1) (2)
  Ling C Hsu (1)
  Eric Vittinghoff (2)
  Annie Vu (1)
  Joshua D Bamberger (1)
  Mitchell H Katz (1) (2)
  
  1. San Francisco Department of Public Health, San Francisco, USA
  2. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, USA
  
• ISSN：1471-2458

文摘

Background Homeless persons with HIV/AIDS have greater morbidity and mortality, more hospitalizations, less use of antiretroviral therapy, and worse medication adherence than HIV-infected persons who are stably housed. We examined the effect of homelessness on the mortality of persons with AIDS and measured the effect of supportive housing on AIDS survival. Methods The San Francisco AIDS registry was used to identify homeless and housed persons who were diagnosed with AIDS between 1996 and 2006. The registry was computer-matched with a housing database of homeless persons who received housing after their AIDS diagnosis. The Kaplan-Meier product limit method was used to compare survival between persons who were homeless at AIDS diagnosis and those who were housed. Proportional hazards models were used to estimate the independent effects of homelessness and supportive housing on survival after AIDS diagnosis. Results Of the 6,558 AIDS cases, 9.8% were homeless at diagnosis. Sixty-seven percent of the persons who were homeless survived five years compared with 81% of those who were housed (p < 0.0001). Homelessness increased the risk of death (adjusted relative hazard [RH] 1.20; 95% confidence limits [CL] 1.03, 1.41). Homeless persons with AIDS who obtained supportive housing had a lower risk of death than those who did not (adjusted RH 0.20; 95% CL 0.05, 0.81). Conclusion Supportive housing ameliorates the negative effect of homelessness on survival with AIDS.